A literature review indicated that the GFRα family, consisting of GFRα1-4, is involved in breast cancer, colorectal cancer, prostate cancer, lung cancer, gastric cancer, and many other tumors, thus exhibiting a diverse oncogenic portfolio. The gene discussed is GFRA1; the disease is breast cancer.